Figure 5From: Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivoResults of trypan blue cell viability assay using SCLC cell line NCI-H460 2 hrs after treatment with increasing concentration of TQ. Cell viability decreased with increasing concentration of TQ and on average only 50% of cells were viable 2 hrs after treatment with various concentration of TQ.Back to article page